Spexis AG announced a private placement for gross proceeds of $2.5 million on August 15, 2023. The transaction will include participation from returning investor SPRIM Ventures for $1 million secured, interest-bearing debt with partial warrant coverage and $1.5 million institutional investors for subordinated debt mandatorily converting into equity.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.063 CHF | -0.94% | +7.14% | +53.66% |
01/05 | SIX Swiss Exchange Approves Delay in Spexis' FY23 Annual Report Publication | MT |
17/04 | Santhera Pharmaceuticals Terminates Cystic Fibrosis Drug License Deal with Spexis | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+53.66% | 4.69M | |
-3.81% | 88.91B | |
+4.08% | 41.25B | |
-15.09% | 31.99B | |
+53.68% | 24.73B | |
-15.13% | 15.54B | |
-8.63% | 12.05B | |
-40.39% | 12.07B | |
+6.22% | 8.84B | |
-6.32% | 8.3B |
- Stock Market
- Equities
- SPEX Stock
- News Spexis AG
- Spexis AG announced that it has received $2.5 million in funding from SPRIM Ventures and other investors